Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005

Jay Raman, Jamie Messer, John A. Sielatycki, Christopher S. Hollenbeak

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

OBJECTIVE • To evaluate epidemiological and survival patterns of upper-tract urothelial carcinoma (UTUC) over the past 30 years through a review of a large, population-based database. PATIENTS AND METHODS • Data from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2005 were reviewed in 10-year increments to evaluate disease trends. • Univariate and multivariate survival analyses identified prognostic variables for outcomes. RESULTS • In total, 13 800 SEER-registered cases of UTUC were included. The overall incidence of UTUC increased from 1.88 to 2.06 cases per 100 000 person-years during the period studied, with an associated increase in ureteral disease (0.69 to 0.91) and a decrease in renal pelvic cancers (1.19 to 1.15). • The proportion of in situ tumours increased from 7.2% to 31.0% (P < 0.001), whereas local tumours declined from 50.4% to 23.6% (P < 0.001). • There was no change in the proportion of patients presenting with distant disease. In multivariate analysis, increasing patient age (P < 0.001), male gender (P < 0.001), black non-Hispanic race (P < 0.001), bilateral UTUC (P= 0.001) and regional/distant disease (P < 0.001) were all associated with poorer survival outcomes. CONCLUSIONS • The incidence of UTUC has slowly risen over the past 30 years. • Increased use of bladder cancer surveillance regimens and improved abdominal cross-sectional imaging may contribute to the observed stage migration towards more in situ lesions. • Although pathological disease characteristics impact cancer outcomes, certain sociodemographic factors also appear to portend worse prognosis.

Original languageEnglish (US)
Pages (from-to)1059-1064
Number of pages6
JournalBJU International
Volume107
Issue number7
DOIs
StatePublished - Apr 1 2011

Fingerprint

Kidney Pelvis
Ureter
Carcinoma
Survival
Incidence
Ureteral Diseases
Epidemiology
Multivariate Analysis
Pelvic Neoplasms
Databases
Neoplasms
Kidney Neoplasms
Survival Analysis
Urinary Bladder Neoplasms
Population

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

@article{58f08d76520f42f4aa24f9e5597ca9e1,
title = "Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005",
abstract = "OBJECTIVE • To evaluate epidemiological and survival patterns of upper-tract urothelial carcinoma (UTUC) over the past 30 years through a review of a large, population-based database. PATIENTS AND METHODS • Data from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2005 were reviewed in 10-year increments to evaluate disease trends. • Univariate and multivariate survival analyses identified prognostic variables for outcomes. RESULTS • In total, 13 800 SEER-registered cases of UTUC were included. The overall incidence of UTUC increased from 1.88 to 2.06 cases per 100 000 person-years during the period studied, with an associated increase in ureteral disease (0.69 to 0.91) and a decrease in renal pelvic cancers (1.19 to 1.15). • The proportion of in situ tumours increased from 7.2{\%} to 31.0{\%} (P < 0.001), whereas local tumours declined from 50.4{\%} to 23.6{\%} (P < 0.001). • There was no change in the proportion of patients presenting with distant disease. In multivariate analysis, increasing patient age (P < 0.001), male gender (P < 0.001), black non-Hispanic race (P < 0.001), bilateral UTUC (P= 0.001) and regional/distant disease (P < 0.001) were all associated with poorer survival outcomes. CONCLUSIONS • The incidence of UTUC has slowly risen over the past 30 years. • Increased use of bladder cancer surveillance regimens and improved abdominal cross-sectional imaging may contribute to the observed stage migration towards more in situ lesions. • Although pathological disease characteristics impact cancer outcomes, certain sociodemographic factors also appear to portend worse prognosis.",
author = "Jay Raman and Jamie Messer and Sielatycki, {John A.} and Hollenbeak, {Christopher S.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1464-410X.2010.09675.x",
language = "English (US)",
volume = "107",
pages = "1059--1064",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "7",

}

Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. / Raman, Jay; Messer, Jamie; Sielatycki, John A.; Hollenbeak, Christopher S.

In: BJU International, Vol. 107, No. 7, 01.04.2011, p. 1059-1064.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005

AU - Raman, Jay

AU - Messer, Jamie

AU - Sielatycki, John A.

AU - Hollenbeak, Christopher S.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - OBJECTIVE • To evaluate epidemiological and survival patterns of upper-tract urothelial carcinoma (UTUC) over the past 30 years through a review of a large, population-based database. PATIENTS AND METHODS • Data from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2005 were reviewed in 10-year increments to evaluate disease trends. • Univariate and multivariate survival analyses identified prognostic variables for outcomes. RESULTS • In total, 13 800 SEER-registered cases of UTUC were included. The overall incidence of UTUC increased from 1.88 to 2.06 cases per 100 000 person-years during the period studied, with an associated increase in ureteral disease (0.69 to 0.91) and a decrease in renal pelvic cancers (1.19 to 1.15). • The proportion of in situ tumours increased from 7.2% to 31.0% (P < 0.001), whereas local tumours declined from 50.4% to 23.6% (P < 0.001). • There was no change in the proportion of patients presenting with distant disease. In multivariate analysis, increasing patient age (P < 0.001), male gender (P < 0.001), black non-Hispanic race (P < 0.001), bilateral UTUC (P= 0.001) and regional/distant disease (P < 0.001) were all associated with poorer survival outcomes. CONCLUSIONS • The incidence of UTUC has slowly risen over the past 30 years. • Increased use of bladder cancer surveillance regimens and improved abdominal cross-sectional imaging may contribute to the observed stage migration towards more in situ lesions. • Although pathological disease characteristics impact cancer outcomes, certain sociodemographic factors also appear to portend worse prognosis.

AB - OBJECTIVE • To evaluate epidemiological and survival patterns of upper-tract urothelial carcinoma (UTUC) over the past 30 years through a review of a large, population-based database. PATIENTS AND METHODS • Data from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2005 were reviewed in 10-year increments to evaluate disease trends. • Univariate and multivariate survival analyses identified prognostic variables for outcomes. RESULTS • In total, 13 800 SEER-registered cases of UTUC were included. The overall incidence of UTUC increased from 1.88 to 2.06 cases per 100 000 person-years during the period studied, with an associated increase in ureteral disease (0.69 to 0.91) and a decrease in renal pelvic cancers (1.19 to 1.15). • The proportion of in situ tumours increased from 7.2% to 31.0% (P < 0.001), whereas local tumours declined from 50.4% to 23.6% (P < 0.001). • There was no change in the proportion of patients presenting with distant disease. In multivariate analysis, increasing patient age (P < 0.001), male gender (P < 0.001), black non-Hispanic race (P < 0.001), bilateral UTUC (P= 0.001) and regional/distant disease (P < 0.001) were all associated with poorer survival outcomes. CONCLUSIONS • The incidence of UTUC has slowly risen over the past 30 years. • Increased use of bladder cancer surveillance regimens and improved abdominal cross-sectional imaging may contribute to the observed stage migration towards more in situ lesions. • Although pathological disease characteristics impact cancer outcomes, certain sociodemographic factors also appear to portend worse prognosis.

UR - http://www.scopus.com/inward/record.url?scp=79953219091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953219091&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2010.09675.x

DO - 10.1111/j.1464-410X.2010.09675.x

M3 - Article

C2 - 20825397

AN - SCOPUS:79953219091

VL - 107

SP - 1059

EP - 1064

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 7

ER -